PetIQ, Inc. Closes Acquisition of Capstar® Portfolio of Products
EAGLE, Idaho, Aug. 03, 2020 (GLOBE NEWSWIRE) — PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication […]
Afya Limited to Report Second Quarter 2020 Financial Results on August 27
NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Aug. 03, 2020 (GLOBE NEWSWIRE) — Afya Limited, or Afya (Nasdaq: AFYA), today […]
CORRECTION: MyoKardia Doses First Patient in Phase 3 VALOR-HCM Trial of Mavacamten
BRISBANE, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — In a release issued under the same headline on Monday, August 3rd […]
North American employers expect most furloughed workers to return by first quarter of 2021
ARLINGTON, Va., Aug. 03, 2020 (GLOBE NEWSWIRE) — A majority of North American employers expect that most of their furloughed […]
UPDATE – Ideal Power Enters into Early Warrant Exercise Transaction
AUSTIN, Texas, Aug. 03, 2020 (GLOBE NEWSWIRE) — On July 31, 2020, Ideal Power Inc. (Nasdaq: IPWR) (the “Company” or […]
Sky Solar Holdings, Ltd. Announces Recent Developments Regarding the Hudson Dispute in the Cayman Islands Court
HONG KONG, Aug. 03, 2020 (GLOBE NEWSWIRE) — Sky Solar Holdings, Ltd. (NASDAQ: SKYS) (“Sky Solar” or the “Company”), a […]
Atossa Therapeutics Receives Approval to Open Clinical Study of AT-301 Nasal Spray Being Developed to Treat COVID-19
SEATTLE, Aug. 03, 2020 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop […]
Aspen Group, Inc. to Participate in the Canaccord Genuity 40th Annual Growth Conference
NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) — Aspen Group, Inc. (“AGI”) (Nasdaq: ASPU), an education technology holding company, announced […]
Cyclerion Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
– IW-6463 and olinciguat top line clinical study results remain on track for late summer and late Q3 2020, respectively –– […]
Liquidia to Report Second Quarter 2020 Financial Results and Provide Corporate Update on August 10, 2020
RESEARCH TRIANGLE PARK, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (Nasdaq:LQDA), a late-stage clinical biopharmaceutical company focused […]
